- Q1 2024 Lucid Diagnostics Inc Earnings Call TranscriptMay 13, 2024$0.95 (+0.59%)Earnings
- Q4 2023 Lucid Diagnostics Inc Earnings Call TranscriptMar 26, 2024$0.99 (-6.60%)Earnings
- Q3 2023 Lucid Diagnostics Inc Earnings Call TranscriptNov 14, 2023$1.3 (+12.07%)Earnings
- Q2 2023 Lucid Diagnostics Inc Earnings Call TranscriptAug 15, 2023$1.49 (+0.34%)Earnings
- Lucid Diagnostics Inc Annual Shareholders Meeting TranscriptJun 21, 2023
- Q4 2022 Lucid Diagnostics Inc Earnings Call TranscriptMar 14, 2023$1.72 (+6.83%)Earnings
- PAVmed Inc, Lucid Diagnostics Inc and Veris Health Inc Strategic Business Update Call TranscriptJan 17, 2023
- Q3 2022 Lucid Diagnostics Inc Earnings Call TranscriptNov 14, 2022$2.27 (+1.79%)Earnings
- Q2 2022 Lucid Diagnostics Inc Earnings Call TranscriptAug 15, 2022$3.35 (-1.18%)Earnings
- Lucid Diagnostics Inc Annual Shareholders Meeting TranscriptJun 21, 2022
- Q1 2022 Lucid Diagnostics Inc Earnings Call TranscriptMay 11, 2022$1.86 (-7.46%)Earnings
- Lucid Diagnostics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 12, 2022
Q2 2023 Lucid Diagnostics Inc Earnings Call Transcript
Good day, and welcome to the Lucid Diagnostics Second Quarter 2023 Business Update Conference Call. (Operator Instructions) Please note, this event is being recorded.
I would now like to turn the conference over to Michael Parks, VP, Investor Relations. Please go ahead.
Thank you, Betsy. Good morning, everyone. Thank you for participating in today's second quarter 2023 business update call.
The press release announcing our business update for the company and financial results for the 3 and 6 months ended June 30, 2023, is available on the Lucid website.
Please take a moment to read the disclaimer about forward-looking statements in the press release. The business update, press release and this conference call include forward-looking statements, and these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from statements made. Factors that could cause actual results to differ are described in the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)